Lihong P. Hu

Jiangsu Key Laboratory For Functional Substance Of Chinese Medicine
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Enzymatic Site-Selective Deglycosylation Enhances PPM1A Agonistic Activity of Dammarane Saponins for the Treatment of Hepatic Fibrosis.

Enzymatic Site-Selective Deglycosylation Enhances PPM1A Agonistic Activity of Dammarane Saponins for the Treatment of Hepatic Fibrosis.

Journal: Journal of medicinal chemistry

Published: July 10, 2026

Arglabin targets a non-canonical NLRP3/CCR2 axis to suppress MDSC infiltration and potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma.

Arglabin targets a non-canonical NLRP3/CCR2 axis to suppress MDSC infiltration and potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 29, 2026

HOXD10 promotes hepatocellular carcinoma progression by enhancing m6A methylation and activating the PI3K/AKT/mTOR pathway.

HOXD10 promotes hepatocellular carcinoma progression by enhancing m6A methylation and activating the PI3K/AKT/mTOR pathway.

Journal: Journal of translational medicine

Published: January 23, 2026

Recent developments in overcoming FLT3 inhibitor resistance.

Recent developments in overcoming FLT3 inhibitor resistance.

Journal: Future medicinal chemistry

Published: January 22, 2026

Rhoifolin Alleviates Ulcerative Colitis by Targeting NMNAT1 and Activating SIRT1-FOXO1 Signaling to Enhance ILC3s Effector Function.

Rhoifolin Alleviates Ulcerative Colitis by Targeting NMNAT1 and Activating SIRT1-FOXO1 Signaling to Enhance ILC3s Effector Function.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 29, 2025

Machine Learning-Guided Generation of Novel Pseudo-Natural Products: Applications to Accelerate Drug Discovery.

Machine Learning-Guided Generation of Novel Pseudo-Natural Products: Applications to Accelerate Drug Discovery.

Journal: Journal of chemical information and modeling

Published: October 18, 2025

Multimodal AI-Driven Identification of Dehydrocostus Lactone as a Potent Renal Fibrosis Attenuator Targeting IQGAP1.

Multimodal AI-Driven Identification of Dehydrocostus Lactone as a Potent Renal Fibrosis Attenuator Targeting IQGAP1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 14, 2025

Immunometabolic control of ILC3s: implications for epithelial barrier homeostasis and inflammation.

Immunometabolic control of ILC3s: implications for epithelial barrier homeostasis and inflammation.

Journal: Biochemical pharmacology

Published: October 11, 2025

Inhibition of DDX5-Mediated G-Quadruplex Unwinding in the β-Catenin 5'-UTR by Magnesium Isoglycyrrhizinate Alleviates Chemotherapy-Induced Intestinal Injury.

Inhibition of DDX5-Mediated G-Quadruplex Unwinding in the β-Catenin 5'-UTR by Magnesium Isoglycyrrhizinate Alleviates Chemotherapy-Induced Intestinal Injury.

Journal: Research (Washington, D.C.)

Published: August 26, 2025

Metal-dependent protein phosphatase 1A: A potential therapeutic target in fibrotic disorders.

Metal-dependent protein phosphatase 1A: A potential therapeutic target in fibrotic disorders.

Journal: Biochemical pharmacology

Published: June 04, 2025

Discovery of Novel Pyrrolo[2,3-b]pyridine-Based CSF-1R Inhibitors with Demonstrated Efficacy against Patient-Derived Colorectal Cancer Organoids.

Discovery of Novel Pyrrolo[2,3-b]pyridine-Based CSF-1R Inhibitors with Demonstrated Efficacy against Patient-Derived Colorectal Cancer Organoids.

Journal: Journal of medicinal chemistry

Published: February 27, 2025

Bony mucoperiosteal flap in bony impacted upper third molar surgery.

Bony mucoperiosteal flap in bony impacted upper third molar surgery.

Journal: International journal of oral and maxillofacial surgery

Published: February 06, 2025

Showing 1-12 of 108

Last Updated: 09/26/2026